Dilemmas in Secondary Stroke Prevention
Stroke2025Vol. 56(7), pp. 1938–1946
Citations Over TimeTop 20% of 2025 papers
Abstract
Secondary stroke prevention encompasses many approaches, including antithrombotic therapy, risk factor management, and a healthy lifestyle. Recommendations are typically based on the results of randomized clinical trials that provide evidence of benefit. However, in some situations, clinicians extrapolate the results of clinical trials into everyday practice, or trials have not provided sufficient information to make treatment decisions. This review will discuss 4 scenarios: dual-antiplatelet therapy, the perils of combining antiplatelet and anticoagulation, indications for statin therapy, and therapeutic considerations for patients with paroxysmal atrial fibrillation.
Related Papers
- → Experimental antithrombotic effect of potatoes harvested in the autumn(2012)5 cited
- → Novel 2-Aminobenzamides as Potential Orally Active Antithrombotic Agents(2012)3 cited
- Investigation on Antithrombotic Effects of Polydatin(2006)
- → Antithrombotic Therapy: Focus on the Elderly(2017)1 cited
- Novel antithrombotic therapy.(1993)